Clinical Trial Results:
A randomised, double-blind, double dummy, active controlled, parallel
group, forced titration study to compare the fixed-dose combination of
Telmisartan 80mg plus Hydrochlorothiazide 25mg (T80/HCTZ25)
versus Telmisartan 80mg (T80) monotherapy as first line therapy in
patients with severe hypertension
Summary
|
|
EudraCT number |
2008-007711-32 |
Trial protocol |
FR BG |
Global completion date |
23 Apr 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 May 2016
|
First version publication date |
06 May 2015
|
Other versions |
|
Summary report(s) |
502.550 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.